Resources from the same session
Optimal management of toxicity in patients with advanced NSCLC treated with EGFR E20I inhibitors: Are they all similar?
Presenter: R. A. Soo, SG
Session: Session 4 – Clinical challenges
Resources:
Slides
Webcast
Are all EGFR E20I mutations similar and are all inhibitors of comparable efficacy?
Presenter: S.H. Lee, KR
Session: Session 4 – Clinical challenges
Resources:
Slides
Webcast